Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients

Figure 4 Decline of platelets of patients with different inosine triphosphate pyrophosphatase genotypes. The percentages of platelet decline of CC and non-CC group patients throughout the 48 wk of combination treatment. It indicates a greater decline of platelet count in the non-CC than CC variants. ^aP < 0.05 at weeks 12, 24 and 48. Error bars indicate standard error.